Literature DB >> 24014642

What's trust got to do with it? Revisiting opioid contracts.

Daniel Z Buchman1, Anita Ho2.   

Abstract

Prescription opioid abuse (POA) is an escalating clinical and public health problem. Physician worries about iatrogenic addiction and whether patients are 'drug seeking', 'abusing' and 'diverting' prescription opioids exist against a backdrop of professional and legal consequences of prescribing that have created a climate of distrust in chronic pain management. One attempt to circumvent these worries is the use of opioid contracts that outline conditions patients must agree to in order to receive opioids. Opioid contracts have received some scholarly attention, with trust and trustworthiness identified as key values and virtues. However, few articles have provided a critical account of trust and trustworthiness in this context, particularly when there exists disagreement about their role in terms of enhancing or detracting from the patient-physician relationship. This paper argues that opioid contracts represent a misleading appeal to patient-physician trust. Assuming the patient is untrustworthy may wrongfully undermine the credibility of the patient's testimony, which may exacerbate certain vulnerabilities of the person in pain. However, misplaced trust in certain patients may render the physician vulnerable to the potential harms of POA. If patients distrust their physician, or feel distrusted by them, this may destabilise the therapeutic relationship and compromise care. A process of epistemic humility may help cultivate mutual patient-physician trust. Epistemic humility is a collaborative effort between physicians and patients that recognises the role of patients' subjective knowledge in enhancing physicians' self-understanding of their theoretical and practice frameworks, values and assumptions about the motivations of certain patients who report chronic pain. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Clinical Ethics; Drugs and Drug Industry; Pain Management; Social Aspects; Substance Abusers/Users of Controlled Substances

Mesh:

Substances:

Year:  2013        PMID: 24014642     DOI: 10.1136/medethics-2013-101320

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  14 in total

1.  Investigating Trust, Expertise, and Epistemic Injustice in Chronic Pain.

Authors:  Daniel Z Buchman; Anita Ho; Daniel S Goldberg
Journal:  J Bioeth Inq       Date:  2016-12-22       Impact factor: 1.352

2.  You Present like a Drug Addict: Patient and Clinician Perspectives on Trust and Trustworthiness in Chronic Pain Management.

Authors:  Daniel Z Buchman; Anita Ho; Judy Illes
Journal:  Pain Med       Date:  2016-01-11       Impact factor: 3.750

3. 

Authors:  Ruth E Dubin; Alan Kaplan; Lisa Graves; Victor K Ng
Journal:  Can Fam Physician       Date:  2017-12       Impact factor: 3.275

4.  Acknowledging stigma: Its presence in patient care and medical education.

Authors:  Ruth E Dubin; Alan Kaplan; Lisa Graves; Victor K Ng
Journal:  Can Fam Physician       Date:  2017-12       Impact factor: 3.275

5.  Project ECHO Telementoring Intervention for Managing Chronic Pain in Primary Care: Insights from a Qualitative Study.

Authors:  Leslie Carlin; Jane Zhao; Ruth Dubin; Paul Taenzer; Hannah Sidrak; Andrea Furlan
Journal:  Pain Med       Date:  2018-06-01       Impact factor: 3.750

Review 6.  Opioids for chronic pain management in patients with dialysis-dependent kidney failure.

Authors:  William C Becker; Michael J Fischer; Daniel G Tobin; Mark B Lockwood; Paul L Kimmel; Laura M Dember; Nwamaka D Eneanya; Manisha Jhamb; Thomas D Nolin
Journal:  Nat Rev Nephrol       Date:  2021-10-07       Impact factor: 28.314

7.  Impact of Informed Consent and Education on Care Engagement After Opioid Initiation in the Veterans Health Administration.

Authors:  Tigran Avoundjian; Lara Troszak; Jennifer Cohen; Mary Beth Foglia; Jodie Trafton; Amanda Midboe
Journal:  J Pain Res       Date:  2022-05-25       Impact factor: 2.832

8.  How Do Clinicians of Different Specialties Perceive and Use Opioid Risk Mitigation Strategies? A Qualitative Study.

Authors:  Michelle S Keller; Alma Jusufagic; Teryl K Nuckols; Jack Needleman; MarySue V Heilemann
Journal:  Subst Use Misuse       Date:  2021-05-22       Impact factor: 2.164

9.  Leaving patients to their own devices? Smart technology, safety and therapeutic relationships.

Authors:  Anita Ho; Oliver Quick
Journal:  BMC Med Ethics       Date:  2018-03-06       Impact factor: 2.652

10.  Fatal attraction: A narrative of early opioid addiction.

Authors:  Willy Pedersen
Journal:  Nordisk Alkohol Nark       Date:  2019-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.